BAx BAX バクスタ― インタ―ナショナル

 BAXのチャート


 BAXの企業情報

symbol BAx
会社名 Baxter International Inc (BAX バクスタ― インタ―ナショナル)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 バクスター・インターナショナル(Baxter International Inc.)は子会社を通じて腎臓及び病院用製品を提供する。同社は2つの事業区分を運営する。病院製品事業は、滅菌静脈内(IV)溶液および投与セット、予混合薬剤および薬剤再構成システム、注射剤、IV栄養製品、非経口栄養療法、輸液ポンプ、吸入麻酔薬およびバイオ手術用製品のための充填済みバイアルおよびシリンジを製造する。レナール事業は、末期腎疾患、または腎臓疾患および急性腎障害の患者のニーズに応じて、腹膜透析(PD)、血液透析(HD)、継続的腎代替療法(CRRT)および追加の透析サービス等のポートフォリオを提供する。同社の製品は、病院、腎臓透析センター、老人ホーム、リハビリテーションセンター、医院、および医師の監督の下で自宅にいる患者によって使用されている。  バクスタ―・インタ―ナショナルは米国の医療機器・医薬品メ―カ―。事業は2部門で構成。バイオサイエンス部門は血友病治療用血漿タンパク製剤などの生物薬剤製品のほか、免疫不全症や止血用の生物学的組織接着剤などの製造を行う。医療製品部門は静脈内投与用の注射器などを製造、腹膜透析用減菌透析液、院内用血液透析装置も扱う。本社はイリノイ州。  Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
本社所在地 One Baxter Parkway Deerfield IL 60015 USA
代表者氏名 Jose E. Almeida
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 847-948-2000
設立年月日 11597
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 50000人
url www.baxter.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 2545.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 41558.95000
売上高 売上高(百万ドル) 11127.00000
企業価値(EV) 企業価値(EV)(百万ドル) 43202.95000
当期純利益 当期純利益(百万ドル) 1423.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Baxter International Inc revenues increased 5% to $11.13B. Net income before extraordinary items increased 9% to $1.42B. Revenues reflect Americas segment increase of 4% to $5.96B EMEA segment increase of 8% to $2.96B APAC segment increase of 5% to $2.21B United States segment increase of 32% to $5.96B Asia pacific segment increase of 5% to $2.21B.

 BAXのテクニカル分析


 BAXのニュース

   SEVEN EIGHT CAPITAL, LP Buys 2, Sells 3 in 2nd Quarter  2022/08/04 19:00:21 GuruFocus
Related Stocks: RBLX , SWN , NKE , WDAY , BAX ,
   Thursday Upgrades Downgrades: Advanced Micro Devices, Baxter, Caesars, Electronic Arts, Gilead Sciences, Intel, JetBlue, Marriott, Match, Microchip Technology, Starbucks, Uber Technologies  2022/08/04 12:56:19 24/7 Wall street
day’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue Airways, Marriott International, Match Group, Microchip Technology, Starbucks and Uber Technologies.
   Baxter International''s Return On Capital Employed Overview  2022/08/02 14:04:23 Benzinga
According to Benzinga Pro, during Q2, Baxter International (NYSE: BAX ) earned $255.00 million, a 249.32% increase from the preceding quarter. Baxter International also posted a total of $3.75 billion in sales, a 1.05% increase since Q1. In Q1, Baxter International earned $73.00 million, and total sales reached $3.71 billion. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of … Full story available on Benzinga.com
   Why Baxter International Stock Is Tumbling Today  2022/07/28 16:18:52 The Motley Fool
Investors weren''t happy with the company''s Q2 update.
   Baxter Shares Plunge After Q2 Earnings Miss, Disappointing FY22 Guidance  2022/07/28 16:07:01 Benzinga
Baxter International Inc (NYSE: BAX ) posted Q2 revenue of $3.75 billion , missing the consensus of $3.88 billion, up 21% on a reported basis, 26% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.87 increased 9%, in line with the consensus and the management guidance. Baxter''s newly acquired Hillrom businesses – Patient Support Systems, Front Line Care, and Surgical Solutions – contributed … Full story available on Benzinga.com
   Global Continuous Glucose Monitoring Device Market 2021-2028, Featuring Key Players Pfizer Inc., Baxter International, Inc, Abbott Laboratories, Medtronic PLC and Animas Corporation - ResearchAndMarkets.com  2021/11/01 13:37:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Continuous Glucose Monitoring Device Market Size, Share & Trends Analysis Report by Component (Transmitters, Sensors), by End Use (Hospitals, Homecare), by Region (Asia Pacific, North America), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com''s offering. The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by 2028. It is expected to expand at a CAGR of 10.1% from 2021 to 2028.
   Baxter International Inc. 2021 Q3 - Results - Earnings Call Presentation  2021/11/01 12:06:40 Seeking Alpha
   Baxter International Inc. to Post FY2021 Earnings of $3.60 Per Share, Piper Sandler Forecasts (NYSE:BAX)  2021/11/01 06:42:41 Transcript Daily
Baxter International Inc. (NYSE:BAX) Piper Sandler upped their FY2021 earnings per share (EPS) estimates for shares of Baxter International in a research note issued to investors on Thursday, October 28th. Piper Sandler analyst M. Obrien now forecasts that the medical instruments supplier will earn $3.60 per share for the year, up from their prior []
   Baxter International Inc. (NYSE:BAX) Given Consensus Recommendation of Buy by Brokerages  2021/10/31 18:34:41 Transcript Daily
Baxter International Inc. (NYSE:BAX) has been assigned an average recommendation of Buy from the fourteen research firms that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued []
   Baxter International (NYSE:BAX) Updates FY21 Earnings Guidance  2021/10/31 14:14:42 Dakota Financial News
Baxter International (NYSE:BAX) issued an update on its FY21 earnings guidance on Thursday morning. The company provided earnings per share guidance of $3.58-3.62 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.52. The company issued revenue guidance of $12.49-12.61 billion, compared to the consensus revenue estimate of $12.61 billion.Baxter []
   Leerink Partners Stick to Their Buy Rating for Baxter International By Investing.com  2021/05/03 07:23:08 Investing.com
Leerink Partners Stick to Their Buy Rating for Baxter International
   ‘Like being in a war zone’: desperate Australians trapped in India as Covid crisis unfolds  2021/04/24 20:00:47 The Guardian
The Baxter family’s repatriation flight was cancelled when the Morrison government imposed new travel restrictions In Bangalore, a city besieged by India’s disastrous second wave of coronavirus, Pippa Baxter and her young family remained stoic. From their empty house, living out of bags packed in anticipation, they could see a way out. Continue reading…
   Hemodialysis and Peritoneal Dialysis Market Size To Reach USD 22.16 Billion, Globally, By 2027 | Baxter International Inc., Nipro Corporation  2021/03/23 12:32:00 OpenPR
Rise in incidences of kidney diseases globally drive the global hemodialysis and peritoneal dialysis market. Furthermore, issues related to kidney transplants and increase in occurrences of lifestyle and chronic diseases supplement the market growth. However, complications in dialysis treatment and
   Baxter International Inc. stock outperforms competitors on strong trading day  2021/03/19 20:39:00 MarketWatch
Shares of Baxter International Inc. inched 0.55% higher to $80.30 Friday, on what proved to be an all-around grim trading session for the stock market, with…
   Clinical Nutrition Market Will Reflect Hugh Growth in Future Say SMI | Major Players Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company, LLC., Perrigo Company PLC.  2021/03/18 10:24:39 OpenPR
Clinical nutrition is concerned with the diagnosis and treatment of diseases that affect the intake, absorption, and metabolism of dietary constituents. Clinical nutrition also promotes the health by preventing diet-related diseases. As the nutrition plays an important role in the

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 BAX バクスタ― インタ―ナショナル BAX )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)